Details for Patent: 10,238,645
✉ Email this page to a colleague
Which drugs does patent 10,238,645 protect, and when does it expire?
Patent 10,238,645 protects ZYCLARA and is included in one NDA.
This patent has twenty-two patent family members in nineteen countries.
Summary for Patent: 10,238,645
Title: | Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
Abstract: | Pharmaceutical formulations and methods for the topical or transdermal delivery of 1isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine or 1-(2-methylpropyl)-1H-imidazo[4,5 c]quinolin-4-amine, i.e., imiquimod, to treat genital/perianal warts with shorter durations of therapy than currently prescribed for the commercially available for Aldara.RTM. 5% imiquimod cream, as now approved by the U.S. Food & Drug Administration ("FDA"), are disclosed and described. More specifically, lower dosage strength imiquimod formulations to deliver an efficacious dose of imiquimod for treating genital/perianal warts with an acceptable safety profile and dosing regimens that are shorter and more convenient for patient use than the dosing regimen currently approved by the U.S. Food & Drug Administration ("FDA") for Aldara.RTM. 5% imiquimod cream to treat genital/perianal warts are also disclosed and described. |
Inventor(s): | Nordsiek; Michael T. (Wayne, PA), Gregory; Jefferson J. (Bristol, TN) |
Assignee: | Medicis Pharmaceutical Corporation (Bridgewater, NJ) |
Application Number: | 15/990,590 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,238,645
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ZYCLARA | imiquimod | CREAM;TOPICAL | 022483-001 | Mar 25, 2010 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF GENITAL WARTS | ⤷ Try a Trial | |||
Bausch | ZYCLARA | imiquimod | CREAM;TOPICAL | 022483-001 | Mar 25, 2010 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PERIANAL WARTS | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,238,645
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 077747 | ⤷ Try a Trial | |||
Australia | 2010274097 | ⤷ Try a Trial | |||
Brazil | 112012000797 | ⤷ Try a Trial | |||
Canada | 2697978 | ⤷ Try a Trial | |||
Chile | 2010000524 | ⤷ Try a Trial | |||
Costa Rica | 20120068 | ⤷ Try a Trial | |||
Dominican Republic | P2012000007 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |